Thierry Chignon is Managing Partner at Mérieux Equity Partners, a registered AMF General Partners. With  more than a billion € under management,  Mérieux Equity Partners actively invests in Health and Nutrition for both humans and animals, combining Venture and Growth/Buy Out investments, for both products and services.

Thierry has more than 30 years of experience in Quality Assurance, Regulatory Affairs, Clinical Trials with particular focus on the medical device sector, including a first operational experience as Head Pharmacist within Institut Mérieux (1988-1997, now Sanofi Pasteur).

Prior to Mérieux Equity Partners, he was partner of Matignon Investissement et Gestion (2006-2014) to raise and deploy the first largest European fund dedicated to medical technologies (Matignon Technologies II, 100M$). After several positive exits (trade sale and IPOs), Thierry joined as Senior Partner Mérieux Développement in early 2014.

Before this Private Equity experience, Thierry was also Director within Quintiles Consulting Europe (1997-2006), he defined and participated to the implementation of business development strategies for innovative products in Europe (market access). Thierry also worked for 5 years as an Expert of the Commission of the European Union drafting Guidelines and Regulations for medical devices. He has chaired several standardization working groups in CEN and ISO (Risk Management), as well as a Eucomed Task Force on Tissue engineering.

Thierry holds a Pharmacy Degree, PharmD, a Master Degree from IEP Paris (Sciences Politiques Paris) and an Executive MBA from HEC Paris.